Department of Emergency Medicine, OHSU School of Medicine, United States.
Department of Emergency Medicine, OHSU School of Medicine, United States.
Resuscitation. 2024 Aug;201:110263. doi: 10.1016/j.resuscitation.2024.110263. Epub 2024 Jun 6.
Evaluate the association between early naloxone use and outcomes after out-of-hospital cardiac arrest (OHCA) with initial non-shockable rhythms.
This study was a secondary analysis of data collected in the Portland Cardiac Arrest Epidemiologic Registry, a database containing details of emergency medical services (EMS)-treated OHCA cases in the Portland, Oregon metropolitan region. Eligible patients had non-traumatic OHCA with an initial non-shockable rhythm and received naloxone by EMS or law enforcement prior to IV/IO access (exposure group). The primary outcome was ROSC at emergency department (ED) arrival. Secondary outcomes included survival to admission, survival to hospital discharge, and cerebral performance category score ≤2 at discharge (good neurologic outcome). We performed multivariable logistic regressions adjusting for age, sex, arrest location, witness status, bystander interventions, dispatch to EMS arrival time, initial rhythm, and county of arrest.
There were 1807 OHCA cases from 2018 to 2021 meeting eligibility criteria, with 57 receiving naloxone before vascular access. Patients receiving naloxone prior to vascular access attempts had higher adjusted odds (aOR [95% CI]) of ROSC at any time (2.14 [1.20-3.81]), ROSC at ED arrival (2.14 [1.18-3.88]), survival to admission (2.86 [1.60-5.09]), survival to discharge (4.41 [1.78-10.97]), and good neurologic outcome (4.61 [1.74-12.19]).
Patients with initial non-shockable OHCA who received law enforcement or EMS naloxone prior to IV/IO access attempts had higher adjusted odds of ROSC at any time, ROSC at ED arrival, survival to admission, survival to discharge, and good neurologic outcome.
评估在初始非除颤性节律的院外心脏骤停(OHCA)中早期使用纳洛酮与结局的关系。
本研究是对俄勒冈州波特兰地区心脏骤停流行病学登记处(一个包含紧急医疗服务(EMS)治疗的 OHCA 病例详细信息的数据库)收集的数据进行的二次分析。合格患者具有初始非除颤性节律的非创伤性 OHCA,并在 IV/IO 通路建立之前接受过 EMS 或执法人员的纳洛酮(暴露组)。主要结局是急诊部(ED)到达时的 ROSC。次要结局包括入院存活率、出院存活率和出院时的神经功能预后评分≤2(良好的神经功能预后)。我们进行了多变量逻辑回归分析,调整了年龄、性别、发病地点、目击者状态、旁观者干预、调度到 EMS 到达时间、初始节律和发病县。
2018 年至 2021 年共有 1807 例符合条件的 OHCA 病例,其中 57 例在血管通路建立前接受了纳洛酮。在尝试建立血管通路之前接受纳洛酮的患者,其任何时间(2.14 [1.20-3.81])、ED 到达时(2.14 [1.18-3.88])、入院存活率(2.86 [1.60-5.09])、出院存活率(4.41 [1.78-10.97])和良好的神经功能预后(4.61 [1.74-12.19])的调整优势比(aOR [95%CI])更高。
在尝试建立 IV/IO 通路之前接受过执法人员或 EMS 纳洛酮的初始非除颤性 OHCA 患者,其任何时间、ED 到达时、入院存活率、出院存活率和良好的神经功能预后的调整优势比更高。